Fingerprint
Dive into the research topics of 'Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically